Overview

Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study evaluated the safety, tolerability and pharmacokinetics of single or multiple doses of EGT0001474.
Phase:
Phase 1
Details
Lead Sponsor:
Theracos
Treatments:
Sodium-Glucose Transporter 2 Inhibitors